Skip to main content
VISIT JANSSEN GLOBAL
 
 
 

South Africa
change location▼

Search
Search

Welcome to Janssen South Africa

Home › Stories & News

Title

Stories

Important Medicine Safety Information

Recommended Calculations Of Contraception Duration After Completion Of Therapy To Minimise The Risk Of Embryotoxicity...

Recommended Calculations Of Contraception Duration After Completion Of Therapy To Minimise The Risk Of Embryotoxicity And Teratogenicity Associated With The Use Of Genotoxic Anticancer Medicines (Including Potential Metabolites)

Johnson & Johnson Statement on COVID-19 Vaccine Contract Disclosures

JOHANNESBURG, September 05, 2023 - Johnson & Johnson supported and worked closely with South Africa in every phase...

Janssen Announces Collaboration with Acino to Strengthen Patient Access in South Africa

JOHANNESBURG, May 15, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson in South Africa (“Janssen”)...

#breakingstigma: It's Okay To Not Be Okay

JOHANNESBURG, March 15 th , 2023 – South Africans are pushed to their mental health limits near daily and Janssen South...

World Cancer Day 2023

JOHANNESBURG, February 4th, 2023 – Cancer can be beaten if diagnosed early enough or managed chronically to ensure a...

Janssen South Africa Welcomes Nine New Interns: YES Graduate Programme

On 1st February 2023, Janssen South Africa welcomed nine new colleagues as part of our 12-month Graduate Programme;...

Janssen South Africa Appoints Ahmed El Hofy as General Manager 

JOHANNESBURG, January 25 th , 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson welcomes its new...

Janssen South Africa: Breaking Depression Media Roundtable  

Media Roundtable on Janssen South Africa's Breaking Depression Campaign, aimed at raising awareness about depression...

UPDATED: Johnson & Johnson Statement on Supply of COVID-19 Vaccine to the African Union and Government of South Africa

UPDATE ADDED June 17, 2021 Johnson & Johnson confirms that doses of its single-shot COVID-19 vaccine will arrive in...

Media Statement   Johnson & Johnson Single-Dose COVID-19 Vaccine Granted Registration by South African Health Products Regulatory Authority

JOHANNESBURG, April 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson (the Company) today...

Johnson & Johnson Confirms Advance Purchase Agreement with the Government of the Republic of South Africa for Janssen’s COVID-19 Vaccine Candidate

Media Statement February 28, 2021 Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson...